Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease

A. Brachat, E. Feist, F. Behrens, N. Blank, N. R. Nirmala, C. Specker, M. Witt, J. Zernicke, A. Martini, G. Junge

Research output: Contribution to journalArticle

Original languageEnglish
JournalPediatric Rheumatology
DOIs
Publication statusAccepted/In press - Sep 28 2015

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health

Cite this

Brachat, A., Feist, E., Behrens, F., Blank, N., Nirmala, N. R., Specker, C., Witt, M., Zernicke, J., Martini, A., & Junge, G. (Accepted/In press). Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease. Pediatric Rheumatology. https://doi.org/10.1186/1546-0096-13-S1-P4